ADC Therapeutics SA ADCT 深 滬
等待開盤 10-07 09:30:00 美东时间
4.43
+0.350
+8.58%
華盛通- 最 高4.67
- 今 開4.23
- 成交量 261.00万股
- 最 低 4.1852
- 昨 收 4.08
- 總市值 4.96亿
- 52周最高 4.67
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.05
- 委 比 99.50%
- 總股本 1.12亿
- 歷史最高 56.59
- 量 比 2.07
- 振 幅 11.88%
- 歷史最低 0.3599
- 每 手 1
- 風險率 0.79%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
LAUSANNE, Switzerland, Oct. 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today anno...
10-02 04:05
ADC Therapeutics Updates Strategic Focus on ZYNLONTA
ADC Therapeutics ( ($ADCT) ) just unveiled an announcement. On September 30, 20...
09-30 21:50
国金证券：首予中国生物制药“买入”评级 目标价11.25港元
国金证券发布研报称，首次覆盖中国生物制药（01177），给予“买入”评级，预测公司2025/2026/2027年实现营业收入334.12/371.66/417...
09-23 14:43
山西证券-百利天恒-688506-EGFR×HER3 ADC有望成为肿瘤基石药物，HER2 ADC展现BIC潜力-250922
（来源：研报虎） 公司点评 百利天恒是布局ADC及多抗的创新药企业。公司核心管线EGFR×HER3双抗ADC iza-bren是潜在的泛肿瘤治疗基石药物，正在...
09-22 15:38
Aduro Clean Technologies to Participate in September Technical Conferences Across Europe and North America
LONDON, Ontario, Sept. 10, 2025 (GLOBE NEWSWIRE) – Aduro Clean Technologies Inc. ("Aduro" or the "Company") announced its participation in three key technical and industry-focused conferences in September 2025. These events provide Aduro with opportunities to showcase its Hydrochemolytic™ Technology, engage with global stakeholders, and build visibility as part of its strategy to advance sustainable innovation and the transition to a circular eco...
09-10 11:00
Top 5 Biotech Stocks With Strong Momentum
Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.
08-28 19:19
Aduro Clean Technologies Reports Fourth Quarter and Fiscal Year 2025 Results and Provides Business Update
Aduro Clean Technologies reported its fiscal year 2025 results, highlighting a revenue decrease and increased operational loss due to scale-up activities. The company advanced pilot plant construction with Zeton and Siemens, broadened feedstock testing, and partnered with NexGen Polymers and Cleanfarms for chemical recycling initiatives. Aduro also completed a successful U.S. public offering, strengthening its balance sheet. The company maintaine...
08-28 11:00
Guggenheim Reiterates Buy on ADC Therapeutics, Maintains $10 Price Target
Guggenheim analyst Michael Schmidt reiterates ADC Therapeutics (NYSE:ADCT) with a Buy and maintains $10 price target.
08-13 21:47
ADC Therapeutics Q2 Adj. EPS $(0.25) Beats $(0.39) Estimate, Sales $18.839M Beat $17.776M Estimate
ADC Therapeutics (NYSE:ADCT) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.39) by 35.9 percent. This is unchanged from the same period last year. The company reported
08-12 19:31
Earnings Scheduled For August 12, 2025
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
